The chemical treatment called "chemotherapy of plants" consists in the "in vivo" administration of substances capable of interfering with the viral replication. The current availability of synthetic molecules with a high chemotherapy index, i.e. with a high ratio between the maximum concentration tolerated and the minimum effective, together with the possibility to further widen the therapeutic window by the use of appropriate nanocarriers, seems to open on the application level of a novel chemical approach to treat plant viral infections. Ribavirin, for example, is a synthetic water-soluble nucleoside that possesses broad spectrum activity against a variety of DNA and RNA plant viruses. As well known, water-soluble drugs are generally difficult to encapsulate in solid particles[1]. Chemical modification of these drugs, such as esterification, may increase their encapsulation efficiency, but may also decrease bioactivity. In this work we have synthesized stable solid monodispersed PLGA (poly-D,L-lactic-co-glycolic acid) NPs with diameters ranging from 50 – 200 nm containing ribavirin by using a microfluidic reactor with a flow-focusing geometry. In the flow-focusing-based microdevice the dispersed organic phase containing PLGA (i.e., acetonitrile) is continuously focused by the continuous phase (i.e.,ribavirin in acetate buffer pH 5.5) using 2 syringe pumps (Fig. 1 left). Previous works carried out in our labs [2] showed an improvement of drugs loading efficiency when using a microfluidic approach in comparison with traditional nanoprecipitation methods for nanoencapsulation. On this basis we optimized Ribavirin loading within PLGA NPs by investigating the influence of different operating conditions, such as polymer molecular weight and concentration, flow rate ratio, τmix, microreactor-focusing channel diameters and length, on nanoparticles’ size and morphology and drug loading. NPs’ characterization was performed by Dynamic light scattering (DLS) measurements (size and Z-potential), and by scanning electron microscopy (SEM). The determination of free ribavirin was carried out spectrophotometrically. Synthesized NPs, although the study is still preliminary, showed significant drug loading and entrapment efficiency[3].
Ribavirin entrapment into PLGA NPs by a novel microfluidic approach / Bramosanti, Marco; Chronopoulou, Laura; Grillo, F.; Valletta, Alessio; Donati, Livia; Pasqua, Gabriella; Palocci, Cleofe. - ELETTRONICO. - (2016). (Intervento presentato al convegno 30th Conference of the European Colloid and Interface Society tenutosi a Rome, Italy nel 4-9/09/2016).
Ribavirin entrapment into PLGA NPs by a novel microfluidic approach
BRAMOSANTI, MARCO;CHRONOPOULOU, LAURA;VALLETTA, ALESSIO;DONATI, LIVIA;PASQUA, Gabriella;PALOCCI, Cleofe
2016
Abstract
The chemical treatment called "chemotherapy of plants" consists in the "in vivo" administration of substances capable of interfering with the viral replication. The current availability of synthetic molecules with a high chemotherapy index, i.e. with a high ratio between the maximum concentration tolerated and the minimum effective, together with the possibility to further widen the therapeutic window by the use of appropriate nanocarriers, seems to open on the application level of a novel chemical approach to treat plant viral infections. Ribavirin, for example, is a synthetic water-soluble nucleoside that possesses broad spectrum activity against a variety of DNA and RNA plant viruses. As well known, water-soluble drugs are generally difficult to encapsulate in solid particles[1]. Chemical modification of these drugs, such as esterification, may increase their encapsulation efficiency, but may also decrease bioactivity. In this work we have synthesized stable solid monodispersed PLGA (poly-D,L-lactic-co-glycolic acid) NPs with diameters ranging from 50 – 200 nm containing ribavirin by using a microfluidic reactor with a flow-focusing geometry. In the flow-focusing-based microdevice the dispersed organic phase containing PLGA (i.e., acetonitrile) is continuously focused by the continuous phase (i.e.,ribavirin in acetate buffer pH 5.5) using 2 syringe pumps (Fig. 1 left). Previous works carried out in our labs [2] showed an improvement of drugs loading efficiency when using a microfluidic approach in comparison with traditional nanoprecipitation methods for nanoencapsulation. On this basis we optimized Ribavirin loading within PLGA NPs by investigating the influence of different operating conditions, such as polymer molecular weight and concentration, flow rate ratio, τmix, microreactor-focusing channel diameters and length, on nanoparticles’ size and morphology and drug loading. NPs’ characterization was performed by Dynamic light scattering (DLS) measurements (size and Z-potential), and by scanning electron microscopy (SEM). The determination of free ribavirin was carried out spectrophotometrically. Synthesized NPs, although the study is still preliminary, showed significant drug loading and entrapment efficiency[3].I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.